These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 32527265)
1. Protease associated domain of RNF43 is not necessary for the suppression of Wnt/β-catenin signaling in human cells. Radaszkiewicz T; Bryja V Cell Commun Signal; 2020 Jun; 18(1):91. PubMed ID: 32527265 [TBL] [Abstract][Full Text] [Related]
2. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Hao HX; Xie Y; Zhang Y; Charlat O; Oster E; Avello M; Lei H; Mickanin C; Liu D; Ruffner H; Mao X; Ma Q; Zamponi R; Bouwmeester T; Finan PM; Kirschner MW; Porter JA; Serluca FC; Cong F Nature; 2012 Apr; 485(7397):195-200. PubMed ID: 22575959 [TBL] [Abstract][Full Text] [Related]
3. Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases. Jiang X; Charlat O; Zamponi R; Yang Y; Cong F Mol Cell; 2015 May; 58(3):522-33. PubMed ID: 25891077 [TBL] [Abstract][Full Text] [Related]
4. USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling. Giebel N; de Jaime-Soguero A; García Del Arco A; Landry JJM; Tietje M; Villacorta L; Benes V; Fernández-Sáiz V; Acebrón SP EMBO Rep; 2021 May; 22(5):e51415. PubMed ID: 33786993 [TBL] [Abstract][Full Text] [Related]
5. Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling. Peng WC; de Lau W; Madoori PK; Forneris F; Granneman JC; Clevers H; Gros P PLoS One; 2013; 8(12):e83110. PubMed ID: 24349440 [TBL] [Abstract][Full Text] [Related]
6. Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondin. Xie Y; Zamponi R; Charlat O; Ramones M; Swalley S; Jiang X; Rivera D; Tschantz W; Lu B; Quinn L; Dimitri C; Parker J; Jeffery D; Wilcox SK; Watrobka M; LeMotte P; Granda B; Porter JA; Myer VE; Loew A; Cong F EMBO Rep; 2013 Dec; 14(12):1120-6. PubMed ID: 24165923 [TBL] [Abstract][Full Text] [Related]
7. Ub and Dub of RNF43/ZNRF3 in the WNT signalling pathway. Colozza G; Koo BK EMBO Rep; 2021 May; 22(5):e52970. PubMed ID: 33938624 [TBL] [Abstract][Full Text] [Related]
8. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer. Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131 [TBL] [Abstract][Full Text] [Related]
9. Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling. Tsukiyama T; Fukui A; Terai S; Fujioka Y; Shinada K; Takahashi H; Yamaguchi TP; Ohba Y; Hatakeyama S Mol Cell Biol; 2015 Jun; 35(11):2007-23. PubMed ID: 25825523 [TBL] [Abstract][Full Text] [Related]
10. RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling. Carmon KS; Gong X; Yi J; Thomas A; Liu Q Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1221-9. PubMed ID: 24639526 [TBL] [Abstract][Full Text] [Related]
11. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Zebisch M; Xu Y; Krastev C; MacDonald BT; Chen M; Gilbert RJ; He X; Jones EY Nat Commun; 2013; 4():2787. PubMed ID: 24225776 [TBL] [Abstract][Full Text] [Related]
12. A finger on the pulse of Wnt receptor signaling. MacDonald BT; He X Cell Res; 2012 Oct; 22(10):1410-2. PubMed ID: 22688894 [TBL] [Abstract][Full Text] [Related]
13. The structural basis of R-spondin recognition by LGR5 and RNF43. Chen PH; Chen X; Lin Z; Fang D; He X Genes Dev; 2013 Jun; 27(12):1345-50. PubMed ID: 23756651 [TBL] [Abstract][Full Text] [Related]
14. The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition. Yu J; Yusoff PAM; Woutersen DTJ; Goh P; Harmston N; Smits R; Epstein DM; Virshup DM; Madan B Cancer Res; 2020 Dec; 80(24):5619-5632. PubMed ID: 33067269 [TBL] [Abstract][Full Text] [Related]
15. Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer. Hao HX; Jiang X; Cong F Cancers (Basel); 2016 Jun; 8(6):. PubMed ID: 27338477 [TBL] [Abstract][Full Text] [Related]
16. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength. de Lau W; Peng WC; Gros P; Clevers H Genes Dev; 2014 Feb; 28(4):305-16. PubMed ID: 24532711 [TBL] [Abstract][Full Text] [Related]
17. E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors. Bugter JM; van Kerkhof P; Jordens I; Janssen E; Tran Ngoc Minh T; Iglesias van Montfort D; Jamieson C; Maurice MM Life Sci Alliance; 2024 Sep; 7(9):. PubMed ID: 38969364 [TBL] [Abstract][Full Text] [Related]
18. LGR4 and LGR5 form distinct homodimers that only LGR4 complexes with RNF43/ZNRF3 to provide high affinity binding of R-spondin ligands. Toh Y; Wu L; Park S; Wang A; Tu J; Yu W; Zuo M; Carmon KS; Liu QJ Sci Rep; 2023 Jul; 13(1):10796. PubMed ID: 37402772 [TBL] [Abstract][Full Text] [Related]
19. Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression. Nam JS; Turcotte TJ; Smith PF; Choi S; Yoon JK J Biol Chem; 2006 May; 281(19):13247-13257. PubMed ID: 16543246 [TBL] [Abstract][Full Text] [Related]
20. Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers. Li S; Lavrijsen M; Bakker A; Magierowski M; Magierowska K; Liu P; Wang W; Peppelenbosch MP; Smits R Oncogene; 2020 Apr; 39(17):3458-3472. PubMed ID: 32103169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]